Core Laboratories (NYSE:CLB) Issues Q1 2026 Earnings Guidance

09 Apr 2026, 14:36 by Teresa Graham · The Cerbat Gem

Core Laboratories (NYSE:CLB – Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.050-0.070 for the period, compared to the consensus EPS estimate of 0.160. The company issued revenue guidance of $119.0 million-$123.0 million, compared to the consensus revenue estimate of $127.2 million.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “hold (c)” rating on shares of Core Laboratories in a research note on Friday, March 27th. Four equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Core Laboratories has an average rating of “Hold” and a consensus target price of $12.50.

Get Our Latest Stock Analysis on Core Laboratories

Core Laboratories Price Performance

NYSE:CLB traded up $0.04 during mid-day trading on Thursday, reaching $16.80. The stock had a trading volume of 73,859 shares, compared to its average volume of 390,997. The stock has a 50-day simple moving average of $17.38 and a two-hundred day simple moving average of $16.20. The stock has a market capitalization of $773.41 million, a PE ratio of 25.10, a P/E/G ratio of 14.25 and a beta of 1.15. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.02 and a quick ratio of 1.51. Core Laboratories has a 12 month low of $9.72 and a 12 month high of $20.36.

Core Laboratories (NYSE:CLB – Get Free Report) last announced its quarterly earnings data on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The business had revenue of $138.26 million for the quarter, compared to analysts’ expectations of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period last year, the firm posted $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, equities analysts anticipate that Core Laboratories will post 0.96 earnings per share for the current year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend was Friday, February 13th. Core Laboratories’s dividend payout ratio (DPR) is 5.97%.

Institutional Trading of Core Laboratories

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Corient Private Wealth LLC bought a new stake in shares of Core Laboratories during the fourth quarter worth $219,000. T. Rowe Price Investment Management Inc. grew its stake in shares of Core Laboratories by 14.8% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,042,208 shares of the oil and gas company’s stock worth $16,707,000 after buying an additional 134,050 shares during the last quarter. XTX Topco Ltd grew its stake in shares of Core Laboratories by 110.9% during the fourth quarter. XTX Topco Ltd now owns 54,273 shares of the oil and gas company’s stock worth $870,000 after buying an additional 28,541 shares during the last quarter. Old West Investment Management LLC bought a new stake in shares of Core Laboratories during the fourth quarter worth $613,000. Finally, AQR Capital Management LLC grew its stake in shares of Core Laboratories by 32.6% during the fourth quarter. AQR Capital Management LLC now owns 49,818 shares of the oil and gas company’s stock worth $799,000 after buying an additional 12,242 shares during the last quarter. Institutional investors own 97.81% of the company’s stock.

About Core Laboratories

(Get Free Report)

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.